Global Human Albumin Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 139991
  • calendar_today Published On: Jan, 2019
  • file_copy Pages: 124
  • list Pharmaceuticals and Healthcare

Albumin-based therapies such as Idelvion (CSL654 rIX-FP) by CSL Behring received marketing approval from the US FDA in March 2016 and from the EMA in May 2016. Apart from these, Albutropin (TV-1106) by Teva Pharmaceuticals, Ampion by Ampio Pharmaceuticals, and Albutein by Grifols (for Alzheimer's disease) are expected to enter the market during the forecast period. 

Scope of the Report:

This report studies the Human Albumin market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Human Albumin market by product type and applications/end industries.

Human albumin was initially used only as a volume replacement therapy; however, extensive research has shown that human albumin has numerous applications in other therapeutic areas as well. For instance, Grifols is exploring the use of the product to stabilize Alzheimer’s disease. Moreover, drugs containing human serum albumin, such as Levemir and Abraxane are used to treat diabetes and metastatic breast cancer, respectively. Furthermore, the on-going research and augmented adoption of albumin in the new therapeutic areas will boost this market’s growth during the predicted period.

The APAC region dominated the global human albumin market and accounted for most of the market share during 2017. China was the highest revenue contributor because of the increased demand for albumin. A rising patient population and easy availability of drugs will aid in the growth of this market. Moreover, the increased awareness about the therapeutic potential of immunoglobulins is expected to affect the growth of this market in APAC.

The global Human Albumin market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Human Albumin.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

CSL Behring

Grifols

Baxalta

Octapharma

Kedrion

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

5% Concentrations

25% Concentrations

Others

Market Segment by Applications, can be divided into

Therapeutics

Drug Formulation & Vaccine

Component of Media

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Human Albumin Market Overview

1.1 Product Overview and Scope of Human Albumin

1.2 Classification of Human Albumin by Types

1.2.1 Global Human Albumin Revenue Comparison by Types (2017-2023)

1.2.2 Global Human Albumin Revenue Market Share by Types in 2017

1.2.3 5% Concentrations

1.2.4 25% Concentrations

1.2.5 Others

1.3 Global Human Albumin Market by Application

1.3.1 Global Human Albumin Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Therapeutics

1.3.3 Drug Formulation & Vaccine

1.3.4 Component of Media

1.3.5 Others

1.4 Global Human Albumin Market by Regions

1.4.1 Global Human Albumin Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Human Albumin Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Human Albumin Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Human Albumin Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Human Albumin Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Human Albumin Status and Prospect (2013-2023)

1.5 Global Market Size of Human Albumin (2013-2023)

2 Manufacturers Profiles

2.1 CSL Behring

2.1.1 Business Overview

2.1.2 Human Albumin Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 CSL Behring Human Albumin Revenue, Gross Margin and Market Share (2016-2017)

2.2 Grifols

2.2.1 Business Overview

2.2.2 Human Albumin Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Grifols Human Albumin Revenue, Gross Margin and Market Share (2016-2017)

2.3 Baxalta

2.3.1 Business Overview

2.3.2 Human Albumin Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Baxalta Human Albumin Revenue, Gross Margin and Market Share (2016-2017)

2.4 Octapharma

2.4.1 Business Overview

2.4.2 Human Albumin Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Octapharma Human Albumin Revenue, Gross Margin and Market Share (2016-2017)

2.5 Kedrion

2.5.1 Business Overview

2.5.2 Human Albumin Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Kedrion Human Albumin Revenue, Gross Margin and Market Share (2016-2017)

3 Global Human Albumin Market Competition, by Players

3.1 Global Human Albumin Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Human Albumin Players Market Share

3.2.2 Top 10 Human Albumin Players Market Share

3.3 Market Competition Trend

4 Global Human Albumin Market Size by Regions

4.1 Global Human Albumin Revenue and Market Share by Regions

4.2 North America Human Albumin Revenue and Growth Rate (2013-2018)

4.3 Europe Human Albumin Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Human Albumin Revenue and Growth Rate (2013-2018)

4.5 South America Human Albumin Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Human Albumin Revenue and Growth Rate (2013-2018)

5 North America Human Albumin Revenue by Countries

5.1 North America Human Albumin Revenue by Countries (2013-2018)

5.2 USA Human Albumin Revenue and Growth Rate (2013-2018)

5.3 Canada Human Albumin Revenue and Growth Rate (2013-2018)

5.4 Mexico Human Albumin Revenue and Growth Rate (2013-2018)

6 Europe Human Albumin Revenue by Countries

6.1 Europe Human Albumin Revenue by Countries (2013-2018)

6.2 Germany Human Albumin Revenue and Growth Rate (2013-2018)

6.3 UK Human Albumin Revenue and Growth Rate (2013-2018)

6.4 France Human Albumin Revenue and Growth Rate (2013-2018)

6.5 Russia Human Albumin Revenue and Growth Rate (2013-2018)

6.6 Italy Human Albumin Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Human Albumin Revenue by Countries

7.1 Asia-Pacific Human Albumin Revenue by Countries (2013-2018)

7.2 China Human Albumin Revenue and Growth Rate (2013-2018)

7.3 Japan Human Albumin Revenue and Growth Rate (2013-2018)

7.4 Korea Human Albumin Revenue and Growth Rate (2013-2018)

7.5 India Human Albumin Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Human Albumin Revenue and Growth Rate (2013-2018)

8 South America Human Albumin Revenue by Countries

8.1 South America Human Albumin Revenue by Countries (2013-2018)

8.2 Brazil Human Albumin Revenue and Growth Rate (2013-2018)

8.3 Argentina Human Albumin Revenue and Growth Rate (2013-2018)

8.4 Colombia Human Albumin Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Human Albumin by Countries

9.1 Middle East and Africa Human Albumin Revenue by Countries (2013-2018)

9.2 Saudi Arabia Human Albumin Revenue and Growth Rate (2013-2018)

9.3 UAE Human Albumin Revenue and Growth Rate (2013-2018)

9.4 Egypt Human Albumin Revenue and Growth Rate (2013-2018)

9.5 Nigeria Human Albumin Revenue and Growth Rate (2013-2018)

9.6 South Africa Human Albumin Revenue and Growth Rate (2013-2018)

10 Global Human Albumin Market Segment by Type

10.1 Global Human Albumin Revenue and Market Share by Type (2013-2018)

10.2 Global Human Albumin Market Forecast by Type (2018-2023)

10.3 5% Concentrations Revenue Growth Rate (2013-2023)

10.4 25% Concentrations Revenue Growth Rate (2013-2023)

10.5 Others Revenue Growth Rate (2013-2023)

11 Global Human Albumin Market Segment by Application

11.1 Global Human Albumin Revenue Market Share by Application (2013-2018)

11.2 Human Albumin Market Forecast by Application (2018-2023)

11.3 Therapeutics Revenue Growth (2013-2018)

11.4 Drug Formulation & Vaccine Revenue Growth (2013-2018)

11.5 Component of Media Revenue Growth (2013-2018)

11.6 Others Revenue Growth (2013-2018)

12 Global Human Albumin Market Size Forecast (2018-2023)

12.1 Global Human Albumin Market Size Forecast (2018-2023)

12.2 Global Human Albumin Market Forecast by Regions (2018-2023)

12.3 North America Human Albumin Revenue Market Forecast (2018-2023)

12.4 Europe Human Albumin Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Human Albumin Revenue Market Forecast (2018-2023)

12.6 South America Human Albumin Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Human Albumin Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Human Albumin Picture

Table Product Specifications of Human Albumin

Table Global Human Albumin and Revenue (Million USD) Market Split by Product Type

Fi

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery